P3 Health Partners Inc.
PIII
$10.03
-$0.28-2.72%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -3.45% | 6.99% | |||
| Total Other Revenue | 189.99% | -77.11% | |||
| Total Revenue | 0.00% | 0.41% | |||
| Cost of Revenue | -10.61% | -21.13% | |||
| Gross Profit | 70.76% | 222.12% | |||
| SG&A Expenses | 25.70% | -28.84% | |||
| Depreciation & Amortization | -0.14% | 0.38% | |||
| Other Operating Expenses | -83.65% | -108.51% | |||
| Total Operating Expenses | -8.73% | -29.80% | |||
| Operating Income | 400.50% | 105.35% | |||
| Income Before Tax | 312.59% | 95.23% | |||
| Income Tax Expenses | 111.50% | -957.40% | |||
| Earnings from Continuing Operations | 414.84% | 101.83% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -351.68% | -102.01% | |||
| Net Income | 508.67% | 101.62% | |||
| EBIT | 400.50% | 105.35% | |||
| EBITDA | 112.45% | 122.06% | |||
| EPS Basic | -270.00% | 101.62% | |||
| Normalized Basic EPS | 134.07% | 51.34% | |||
| EPS Diluted | -298.62% | 100.69% | |||
| Normalized Diluted EPS | 187.22% | 86.94% | |||
| Average Basic Shares Outstanding | 2.25% | 0.21% | |||
| Average Diluted Shares Outstanding | -60.06% | -19.69% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||